You are here: Welcome » COVID-19 » COVID-19 Treatments and Philosophies » Drug Therapies Researched or Applied to Treat COVID-19 » Ivermectin for the Prevention or Treatment of COVID-19

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision		Previous revision
Both sides next revision
covid-19:treatments:drug_therapies:ivermectin [2022/01/06 15:43]
robert [Educational Content] 		covid-19:treatments:drug_therapies:ivermectin [2023/05/04 18:10] (current)
gabriel [Link Dump]
Line 17: Line 17:
  
 ==== Prophylaxis Research ==== ==== Prophylaxis Research ====
 +October 28, 2021: 'Ivermectin Prophylaxis Survey of 306 Health Care Workers in India' by Ajay Kumar Verma et. al., published in the //Indian Journal of Community Health// 
 +(([[http://www.iapsmupuk.org/journal/index.php/IJCH/article/view/2221|Assessing Knowledge, Attitude, and Practices towards Ivermectin Pre-exposure Prophylaxis for COVID-19 among Health Care Workers.]]))
 +
 +January 15, 2022: 'Ivermectin Prophylaxis Used for COVID-19: A Citywide, Prospective, Observational Study of 223,128 Subjects Using Propensity Score Matching' Kerr L, Cadegiani F A, Baldi F, et al. (January 15, 2022) Ivermectin Prophylaxis Used for COVID-19: A Citywide, Prospective, Observational Study of 223,128 Subjects Using Propensity Score Matching. Cureus 14(1): e21272. doi:10.7759/cureus.21272((https://www.cureus.com/articles/82162-ivermectin-prophylaxis-used-for-covid-19-a-citywide-prospective-observational-study-of-223128-subjects-using-propensity-score-matching))
 +
 +“When adjusted for residual variables, reduction in mortality rate was 70%. After adjustment for residual variables, reduction in hospitalization rate was 67%.
 +
 +Conclusion: In this large PSM study, regular use of ivermectin as a prophylactic agent was associated with significantly reduced COVID-19 infection, hospitalization, and mortality rates.”
 +
 +==== Therapeutic Research ====
 +Retrospective analysis of 92 severe Covid-19 patients by Dr. Jackie Stone et. al., pre-print posted on 09 Nov, 2021.(([[https://www.researchsquare.com/article/rs-1048271/v1|
 +Rapid increase of SpO2 on room air for 34 severe COVID-19 patients after ivermectin-based combination treatment: 55-62% normalization within 12-24 hours]]))
  
-==== Therapeudic Research ==== 
-Retrospective analysis of 92 severe Covid-19 patients\\ by Dr. Jackie Stone et. al\\ pre-print posted on 09 Nov, 2021\\ 
-[[https://www.researchsquare.com/article/rs-1048271/v1| 
-Rapid increase of SpO2 on room air for 34 severe COVID-19 patients after ivermectin-based combination treatment: 55-62% normalization within 12-24 hours]] 
  
-Ivermectin [[Prophylaxis]] Survey of 306 Health Care Workers in India\\ by Ajay Kumar Verma et. al. \\ Published in the //Indian Journal of Community Health// October 28, 2021\\  
-[[http://www.iapsmupuk.org/journal/index.php/IJCH/article/view/2221|Assessing Knowledge, Attitude, and Practices towards Ivermectin Pre-exposure Prophylaxis for COVID-19 among Health Care Workers.]] 
  
 ==== Meta-Analyses of Ivermectin Efficacy ==== ==== Meta-Analyses of Ivermectin Efficacy ====
Line 170: Line 176:
 Alexandros Marinos rebuttal to Scott Alexander piece: Alexandros Marinos rebuttal to Scott Alexander piece:
 https://doyourownresearch.substack.com/p/a-conflict-of-blurred-visions?showWelcome=true https://doyourownresearch.substack.com/p/a-conflict-of-blurred-visions?showWelcome=true
 +
 +Australia Removal of prescribing restrictions on ivermectin https://www.tga.gov.au/news/media-releases/removal-prescribing-restrictions-ivermectin
 +
Back to top